netrashetty
Netra Shetty
AmerisourceBergen NYSE: ABC is a Chesterbrook, PA based Drug Wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. They provide drug distribution and related services designed to reduce costs and improve patient outcomes, distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to a wide variety of health care providers located throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as skilled nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients. It is a market leader in pharmaceutical distribution and ranked 24th on the Fortune 500 list for 2010 with over $71 Billion in revenue. [1]
AmerisourceBergen Corporation (NYSE:ABC), the leading pharmaceutical distribution and services company in the U.S., today announced that it has appointed 20 key members of its executive leadership team as it moves to rapidly capitalize on integration opportunities.
The Company was created through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation on August 29, 2001.
Previously, the AmerisourceBergen had named six senior executives: R. David Yost, President and Chief Executive Officer; Kurt J. Hilzinger, Executive Vice President and Chief Operating Officer; Neil F. Dimick, Executive Vice President and Chief Financial Officer; Brent R. Martini, Senior Vice President and President AmerisourceBergen Drug Company; Charles J. Carpenter, Senior Vice President and President PharMerica; and Steven H. Collis, Senior Vice President and President AmerisourceBergen Specialty Group.
"These new appointments reflect the strength of both previous companies and will provide solid, aggressive and innovative leadership for AmerisourceBergen," said Yost. "This new team will move quickly to focus the entire company on building shareholder value, expanding customer service and programs, and increasing the efficiency of the pharmaceutical supply chain."
uly 1, 2011. The AmerisourceBergen Board of Directors has named Steven H. Collis, age 49, to succeed Yost, also effective July 1, 2011.
“Ten years after we announced the merger that created AmerisourceBergen, I am announcing my plans to retire,” said Yost. “With our strong position in the growth areas of the pharmaceutical supply chain, generics and specialty pharmaceuticals, I believe the Company is exceptionally well-positioned for continued success, and that the Company’s future has never been brighter. With Steve’s leadership, I am confident that AmerisourceBergen will take full advantage of the opportunities that lie ahead.”
“On a personal note, I am almost 64 years old and have been with the Company for almost 37 years, and CEO for 14 years,” continued Yost. “There are many things I’d like to do with my wife, my family, and my grandchildren, and other interests I would like to pursue while I am still in good health and I look forward to getting started on that chapter of my life.”
“Dave has done a superb job during his 14 years as the Chief Executive Officer of AmerisourceBergen and its predecessor company,” said Richard C. Gozon, Chairman of the Board of AmerisourceBergen. “Most notably, he has developed a very talented and results-oriented management team. The Board of Directors has every confidence that under the leadership of Steve Collis, the Company will continue to deliver the outstanding performance that AmerisourceBergen stakeholders have come to expect.”
Collis is currently President and Chief Operating Officer, responsible for all AmerisourceBergen business units including AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS), and AmerisourceBergen Packaging Group (ABPG). Before being promoted to his current position in November 2010, Collis was Executive Vice President AmerisourceBergen and President of ABDC, the Company’s largest subsidiary with revenues over $60 billion. Over his 17 year tenure with the Company, he founded ABSG and was the driving force behind growing the business into the market-leader it is today, with $16 billion in annualized revenues.
“Steve’s experience and skills make him eminently qualified to be the next CEO of AmerisourceBergen,” said Yost. “The Company has great momentum, a seasoned and proven management team, and a superb customer-focused, cost conscious culture. I have no doubts that Steve will continue to grow our business and provide value to our customers, suppliers, shareholders and our associates.”
AmerisourceBergen Corporation (NYSE:ABC), the leading pharmaceutical distribution and services company in the U.S., today announced that it has appointed 20 key members of its executive leadership team as it moves to rapidly capitalize on integration opportunities.
The Company was created through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation on August 29, 2001.
Previously, the AmerisourceBergen had named six senior executives: R. David Yost, President and Chief Executive Officer; Kurt J. Hilzinger, Executive Vice President and Chief Operating Officer; Neil F. Dimick, Executive Vice President and Chief Financial Officer; Brent R. Martini, Senior Vice President and President AmerisourceBergen Drug Company; Charles J. Carpenter, Senior Vice President and President PharMerica; and Steven H. Collis, Senior Vice President and President AmerisourceBergen Specialty Group.
"These new appointments reflect the strength of both previous companies and will provide solid, aggressive and innovative leadership for AmerisourceBergen," said Yost. "This new team will move quickly to focus the entire company on building shareholder value, expanding customer service and programs, and increasing the efficiency of the pharmaceutical supply chain."
uly 1, 2011. The AmerisourceBergen Board of Directors has named Steven H. Collis, age 49, to succeed Yost, also effective July 1, 2011.
“Ten years after we announced the merger that created AmerisourceBergen, I am announcing my plans to retire,” said Yost. “With our strong position in the growth areas of the pharmaceutical supply chain, generics and specialty pharmaceuticals, I believe the Company is exceptionally well-positioned for continued success, and that the Company’s future has never been brighter. With Steve’s leadership, I am confident that AmerisourceBergen will take full advantage of the opportunities that lie ahead.”
“On a personal note, I am almost 64 years old and have been with the Company for almost 37 years, and CEO for 14 years,” continued Yost. “There are many things I’d like to do with my wife, my family, and my grandchildren, and other interests I would like to pursue while I am still in good health and I look forward to getting started on that chapter of my life.”
“Dave has done a superb job during his 14 years as the Chief Executive Officer of AmerisourceBergen and its predecessor company,” said Richard C. Gozon, Chairman of the Board of AmerisourceBergen. “Most notably, he has developed a very talented and results-oriented management team. The Board of Directors has every confidence that under the leadership of Steve Collis, the Company will continue to deliver the outstanding performance that AmerisourceBergen stakeholders have come to expect.”
Collis is currently President and Chief Operating Officer, responsible for all AmerisourceBergen business units including AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS), and AmerisourceBergen Packaging Group (ABPG). Before being promoted to his current position in November 2010, Collis was Executive Vice President AmerisourceBergen and President of ABDC, the Company’s largest subsidiary with revenues over $60 billion. Over his 17 year tenure with the Company, he founded ABSG and was the driving force behind growing the business into the market-leader it is today, with $16 billion in annualized revenues.
“Steve’s experience and skills make him eminently qualified to be the next CEO of AmerisourceBergen,” said Yost. “The Company has great momentum, a seasoned and proven management team, and a superb customer-focused, cost conscious culture. I have no doubts that Steve will continue to grow our business and provide value to our customers, suppliers, shareholders and our associates.”